Dr. Henningfield: "Dr. Henningfield is a Principal at, and derives most of his income from, Pinney Associates, a firm that currently provides to GSK on an exclusive basis consulting services regarding smoking-cessation products. His formal title is: Vice President, Research & Health Policy. Through his association with Pinney Associates, Dr. Henningfield advises GSK specifically on the development of nicotine-replacement therapies and treatments for tobacco dependence. Pinney Associates has received on average more than $2 million per year in revenue from pharmaceutical companies, more than half of which relates to smoking-cessation products. In addition, during the last decade, Dr. Henningfield has received grant support for research and writing from GSK on at least eight occasions. Dr. Henningfield is also a partner in a company that holds patents for a nicotine replacement-therapy product. He has estimated that, if thess patents are successfully licensed, they could be worth more than $1 million to him as a partner in that company. Thus, Dr. Henningfield has a financial interest in bringing about regulatory policies that will drive current smokers to use nicotine-replacement-therapy products."

•Ads must make clear that the product is an e-cigarette and not a tobacco product

1. Mayo Clinic web site

5. In 2009, Senator Rockefeller sponsored and supported legislation that protected menthol cigarettes by exempting them from the flavored cigarette ban in the Family Smoking Prevention and Tobacco Control Act.

Every day . Smoking tobacco is the biggest cause of preventable death in the world. We all know smoking kills, yet for some strange reason smokers still smoke.There are two types of thought on how to address this problem:

LAST：china estronsmoke 2014 Estron bagua mod bagua mechanical mod |NEXT：vaporizers wholesale & weed smoking pen vaporizer & vapor cigarette wholesale